INCOME STATEMENT
Emcure Pharmaceuticals Ltd.
BSE
Jun 16, 09:49
1335.05
-27.65 ( -2.03%)
Volume
898
Prev. Close
1362.70
Open Price
1320.05
Bid Price(Qty.)
1336.35 (12)
Offer Pr.(Qty.)
1339.90 (16)
NSE
Jun 16, 09:34
1348.80
-12.60 ( -0.93%)
Volume
8027
Prev. Close
1361.40
Open Price
1362.20
Bid Price(Qty.)
1348.60 (50)
Offer Pr.(Qty.)
1349.80 (10)
You can view the
Income Statement
for the last 5 years.
|
ISIN No
|
INE168P01015
|
Market Cap. ( ₹ in Cr. )
|
25560.89
|
P/BV
|
6.21
|
Book Value ( ₹ )
|
217.34
|
|
BSE Code
|
544210
|
52 Week High/Low ( ₹ )
|
1580/889
|
FV/ML
|
10/1
|
P/E(X)
|
37.52
|
|
NSE Code
|
EMCUREEQ
|
Book Closure
|
|
EPS ( ₹ )
|
35.95
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 4381.92 | 3468.98 | 3088.99 | 3378.93 | 3127.20 |
| Other Operating Revenues | 0.00 | 28.68 | 18.09 | 8.32 | 26.46 |
| Total Operating Revenues | 4381.92 | 3497.66 | 3107.09 | 3387.24 | 3153.66 |
| | | | | | |
| Other Income | 118.81 | 138.26 | 125.35 | 132.68 | 111.91 |
| Total Revenue | 4500.73 | 3635.91 | 3232.44 | 3519.92 | 3265.57 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 1307.98 | 1087.82 | 938.87 | 1072.09 | 1047.32 |
| Purchase Of Stock-In Trade | 825.70 | 376.85 | 260.38 | 282.90 | 307.04 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -126.27 | -101.70 | 14.45 | -36.10 | -107.96 |
| Employee Benefit Expenses | 782.31 | 706.41 | 649.18 | 603.95 | 550.96 |
| Finance Costs | 112.96 | 166.09 | 166.83 | 145.14 | 123.34 |
| Depreciation And Amortisation Expenses | 224.97 | 204.83 | 178.52 | 165.79 | 156.24 |
| Other Expenses | 945.37 | 986.39 | 805.72 | 669.74 | 612.90 |
| Total Expenses | 4073.02 | 3426.69 | 3013.95 | 2903.50 | 2689.84 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 427.71 | 209.23 | 218.48 | 616.42 | 575.74 |
| | | | | | |
| Exceptional Items | 0.00 | -9.32 | -6.15 | 0.00 | -18.29 |
| Profit/Loss Before Tax | 427.71 | 199.91 | 212.34 | 616.42 | 557.45 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 110.58 | 38.58 | 51.05 | 152.62 | 144.29 |
| Deferred Tax | 0.00 | 0.50 | -0.83 | 0.89 | -4.15 |
| Tax For Earlier Years | 0.00 | 0.00 | 2.05 | 16.10 | -3.17 |
| Total Tax Expenses | 110.58 | 39.08 | 52.28 | 169.61 | 136.97 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| | | | | | |
| Profit/Loss From Continuing Operations | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| | | | | | |
| Profit/Loss For The Period | 317.13 | 160.83 | 160.06 | 446.81 | 420.48 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| Diluted EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 54.26 | 36.17 | 54.26 | 18.09 |
| Equity Dividend Rate (%) | 0.00 | 30.00 | 20.00 | 10.00 | 10.00 |